Avastin® Antineoplastic agent, monoclonal antibodies Concentrate for the preparation of a solution for infusions of 100 mg / 4 ml and 400 mg / 16 ml. Actemra® Antibodies monoclonal Concentrate for the preparation of a solution for infusions of 20 mg / ml. Actemra® Solution for subcutaneous administration. Bactrim® Antimicrobial combination Suspension for oral administration 240 mg / 5 ml. Bactrim® forte Antimicrobial combination Tablets coated with a coating, 960 mg. Bonviva® Bone resorption inhibitor-bisphosphonate Tablets, film-coated, 150 mg Bondronate® Bone resorption inhibitor-bisphosphonate Tablets, film-coated, 50 mg. Valcit® Antiviral agent Tablets, film-coated, 450 mg. Herceptin® Antineoplastic agent - monoclonal antibodies. Solution for subcutaneous administration 600 mg / 5 ml. Herceptin® Antineoplastic agent - monoclonal antibodies. Liofilizate for the preparation of concentrate for the preparation of a solution for infusions 440 mg. Herceptin® Antineoplastic agent - monoclonal antibodies. Liofilizate for the preparation of a solution for infusions 150 mg Dilatrend® Alpha- and beta-blocker Tablets 6.25 mg, 12.5 mg and 25 mg. Dormicum® The drug belongs to the List III of the list of narcotic, psychotropic substances and their precursors subject to control in the Russian Federation. Solution for intravenous and intramuscular injection 5 mg / 1 ml and 15 mg / 3 ml. Zelborab® antitumor agent Tablécoated with film, 240 mg. Zenapax Immunosuppressive remedy Concentrate for the preparation of solution for infusion. Invirase® An antiviral [HIV] agent. Tablets coated with a coating, 500 mg Incibice® Angiotensin-converting enzyme (ACE) inhibitor Tablets, film-coated, 1 mg, 2.5 mg, 5 mg. Kadsila® Antineoplastic agent - monoclonal antibodies. Liofilizate for the preparation of concentrate for the preparation of a solution for infusions of 100 mg and 160 mg. Kitryl® Antiemetic means - serotonin receptor antagonist Tablets, film-coated, 1 mg. Cotellick antitumor agent - protein tyrosine kinase inhibitor Tablets, film-coated, 20 mg. Xeloda® Antitumour agent, antimetabolite Film-coated tablets, 150 mg and 500 mg. Xenical® GI lipase inhibitor Capsules 120 mg Lariam® Anti-malarial drug Tablets, 250 mg. MabThera® Antitumor and immunomodulating agent - antibodies monoclonal. A solution for subcutaneous administration of 1400 mg / 11.7 ml MabThera® Antitumor and immunomodulating agent - antibodies monoclonal. Concentrate for the preparation of a solution for infusions of 100 mg / 10 ml and 500 mg / 50 ml. Madopar® "125" An antiparkinsonian agent (dopamine precursor + decarboxylase peripheral inhibitor). Capsules 100 mg + 25 mg Madopar® "250" An antiparkinsonian agent (dopamine precursor + decarboxylase peripheral inhibitor). Dispersible tablets 100 mg + 25 mg, capsules 100 mg + 25 mg, tablets 200 mg + 50 mg, modified-release capsules (capsules GSS) 100 mg + 25 mg. Madopar ® high-speed tablets (dispersible) "125" An antiparkinsonian agent (dopamine precursor + decarboxylase peripheral inhibitor). Tablets are dispersible 100 mg + 25 mg. capsules 100 mg + 25 mg, tablets 200 mg + 50 mg, modified-release capsules (capsules GSS) 100 mg + 25 mg. Madopar®GSS "125" An antiparkinsonian agent (dopamine precursor + decarboxylase peripheral inhibitor). Capsules with modified release (capsules GSS) 100 mg + 25 mg.Tablets are dispersible 100 mg + 25 mg. Capsules 100 mg + 25 mg, tablets 200 mg + 50 mg. Mircera® Other anti-anemic drugs Solution for subcutaneous and intravenous administration Mircera® Other anti-anemic drugs Solution for subcutaneous and intravenous administration. Neupogen® leukopoiesis stimulant A solution for subcutaneous administration, 30 million units / 0.5 ml, 48 million units / 0.5 ml. Neupogen® leukopoiesis stimulant Solution for intravenous and subcutaneous administration, 30 million units / ml. Neuralim® ejkopoeza stimulant Solution for subcutaneous administration, 6 mg / 0.6 ml. Pegasys® cytokine Solution for subcutaneous administration, 135 μg / 0.5 ml and 180 μg / 0.5 ml. Perieta® Antitumor agent, antibodies monoclonal. Concentrate for the preparation of a solution for infusions 420 mg / 14 ml 420 mg / 14 ml of the drug in a bottle of colorless glass (hydrolytic class 1 EF), sealed with a plug of butyl rubber laminated with fluoropolymer, crimped with an aluminum cap and closed with a plastic lid. 1 bottle with the drug, along with instructions for use, is placed in a cardboard box. Pulmozim® mucolytic agent Solution for inhalation, 2.5 mg / 2.5 ml. Recormon® hematopoiesis stimulant Syringe tubes 1000 IU / 0.3 ml. 2000 IU / 0.3 mL, 10,000 IU / 0.6 mL, 20,000 IU / 0.6 mL. 30000 IU / 0.6 ml Recormon® hematopoiesis stimulant Syringe tubes 1000 IU / 0.3 ml. 2000 IU / 0.3 ml. 10,000 IU / 0.6 ml. 20000 IU / 0.6 ml. 30000 IU / 0.6 ml Roaccutane® A remedy for acne. Capsules 10 mg and 20 mg. Rocaltrol® Vitamin - calcium-phosphorus exchange regulator Capsules 0.25 μg or 0.5 μg Roferon®-A MIBP (medical immunobiological preparations) is an antiviral and antitumor agent. Solution for subcutaneous administration 3 million IU / 0.5 ml, 4.5 million IU / 0.5 ml, 6 million IU / 0.5 ml, 9 million IU / 0.5 ml. Rocefin® Antibiotic-cephalosporin Powder for solution for infusion 2 g. SellSept® Immunosuppressive remedy. Capsules 250 mg. Tamiflu® Antiviral agent Capsules 75 mg Tamiflu® Antiviral agent Powder for the preparation of suspension for reception inwards 12 mg / 1 ml Tarceva® antitumor agent - protein tyrosine kinase inhibitor Film coated tablets, 25 mg, 100 mg and 150 mg. Fancidar® Anti-malarial means. Tablets 500 mg / 25 mg. Fuzeon® antiviral [HIV] agent Lyophilizate for the preparation of a solution for subcutaneous administration of 90 mg / ml Tzymoven Antiviral agent Lyophilizate for solution for infusion, 500 mg. Erivage ™ Antitumor agent Capsules 150 mg Esbriet Immunosuppressive remedy Capsules, 267 mg.